NeuroImaging Nowadays in multiple sclerosis (MS)
Dive into theory of neuroimaging and MS on a global virtual platform with renowned international speakers
NeuroImaging Nowadays in multiple sclerosis (MS) is the most recent online platform that aims to discuss the theory and clinical practice behind neuroimaging in multiple sclerosis and beyond.
We are presenting a course comprised of 9 modules, focusing on nine different themes in MS and its diagnosis & monitoring through neuroimaging.
We have invited several international experts to discuss and present their opinion on the subject. We invite you to participate in this international project to learn and discover more about MS and neuroimaging.
After you have fully taken the program and answered the quiz, you will receive a certificate of completion.
Start developping your knowledge now and get certified!
-
The purpose behind the course
- Provide a unique learning and training experience in MS and other demyelinating diseases and Neuroimaging
- Foster knowledge on MS diagnosis and differential diagnosis, disease monitoring, prediction of treatment response, and assessment of treatment efficacy & safety
- Empower Neurologists, Neuroradiologists, Radiologists and Residents with an interest in MRI and MS
-
MS & Neuroimaging
Multiple sclerosis (MS) is a chronic autoimmune demyelinating inflammatory and degenerative disease of the central nervous system, characterized by the presence of inflammatory lesions in the brain and spinal cord. It is most commonly diagnosed in people in their 20s and 30s, although it can develop at any age. It is about 2 to 3 times more common in women than men. To diagnose multiple sclerosis and evaluate the progression of the disease, magnetic resonance imaging is often the most reliable test because of its high sensibility and specificity in detecting demyelinating lesions. It also allows for differential diagnosis and assessment of the response to the therapeutic.
-
Learning modules
Module 1 | MRI and the diagnosis of MS
- Overview of MRI in MS
- Conventional MRI techniques
- Current diagnostic criteria: 2017 Revised McDonald criteria
Christian Enzinger, Austria - Lina Savsek, Slovenia
Module 2 | MRI and MS monitoring: disease activity and progression
- Brain MRI for MS treatment efficacy monitoring
- Brain MRI for MS prognosis
- Brain MRI for MS safety monitoring
Cristina Granziera, Switzerland - Mike Wattjes, Germany
Module 3 | MRI and multiple sclerosis misdiagnosis and differential diagnosis: Pearls and oyster
- Reasons for misdiagnosis of MS
- McDonald 2017 - focus on specificity
- Red flags on imaging: MS mimics
Mike Wattjes, Germany
Module 4 | Radiologists and Neurologists: chances and challenges in communicating in current times
- How to improve communication between neurology and radiology? Moving things forward
- Standards in reporting of the neurological exam
- best and worst practice examples
Alex Rovira, Spain - Jan Casselman, Belgium - Melissa Cambron, Belgium - Jaume Sastre-Garriga, Spain
Module 5 | The role of spinal cord in MRI: diagnosing, monitoring and predicting treatment response in MS
- Value of spinal cord MRI
- Standardize spinal cord image acquisition
- Spinal cord MRI: diagnosis, differential diagnosis and treatment monitoring
Jiwon Oh, Canada - David K. B. Li, Canada
Module 6 | Optic Nerve MRI And Optical Coherence Tomography (OCT)
- Value of optic nerve MRI
- Role of OCT in MS
- Correlations between brain or optic nerve adnormalities on MRI, and retinal pathology using OCT
Hugh Kearney, Ireland - Axel Petzold, UK
Module 7 | MRI features of specific MS populations and other CNS inflammatory diseases
- Pediatric MS
- Elderly MS patients
- Pregnancy and Breastfeeding in women with MS
- Atypical Demyelination
- Intricacies of progressive vs. relapsing MS
Thomas Berger, Austria - Kerstin Hellwig , Germany - Christian Enzinger, Austria - Klaus Schmierer, UK
Module 8 | Brain and spinal cord atrophy in clinical practice: evidence and barriers to implementation
- Physiological atrophy & clinical relevance of volume changes in patients with MS
- Value of volume changes to predict treatment response in patients with MS
- Atrophy in clinical practice: evidence and barriers to implementation
Jožef Magdič, Slovenia - Jaume Sastre-Garriga, Spain
Module 9 | Neuroimaging and MS: future prospects
- Neuroimaging and MS: MS future prospects
- MRI and MS: future challenges and developments
- Neuronal repair and remyelination: from biology to therapy
- Advanced and emerging MRI techniques
- Other neuroimaging techniques
- Big data and deep learning: new avenues for MRI research in MS?
Pedro Abreu, Portugal - Daniela Jardim Pereira, Portugal - Stéphane Kremer & Jérôme De Sèze, France - João Duarte, Portugal - Cristina Granziera, Switzerland
-
Scientific Committee
Christian Enzinger, MD, MBA, FEAN
Neurologist
Dept. of Neurology Medical University of Graz, Austria
Daniela Jardim Pereira, MD
Neuroradiologist
Coimbra Hospital and Universitary Centre, Coimbra, Portugal
Pedro Abreu, MD
Neurologist
University Hospital Center of São João, Porto, Portugal
Moke Wattjes, MD, PHD
Neuroradiologist
Hannover Medical School, Germany
Thomas Berger, MD, MSc, FEAN
Neurologist
Dept. of Neurology, Medical University of Vienna, Austria
Uroš Rot, MD, PhD
Neurologist
University Medical Centre Ljubljana and Faculty of Medicine, University of Ljubljana, Slovenia
Endorsements
Endorsed by several scientific societies, including for Belgium: